Abstract
Pterygium is an inflammatory, vascular and degenerative disorder with unknown aetiology. The aim of this study was to evaluate the changes in neopterin levels, reflecting T-cell immunity, and the kynurenine pathway, the main degradation process of tryptophan, in pterygium. For this purpose, neopterin concentrations were measured in serum and tear samples by enzyme-linked immunosorbent assay (ELISA) in pterygium patients (n=31) and control group (n=32). Kynurenine (KYN) and tryptophan (TRP) serum levels were simultaneously determined by high-performance liquid chromatography (HPLC) for evaluation of the kynurenine pathway. Serum neopterin concentrations and kynurenine to tryptophan ratio (KYN/TRP) as an index of tryptophan breakdown were found increased in pterygium compared to controls (p<0.05). Although there was a 3-fold difference observed between serum and tear neopterin levels, no significant relationship was found. It can be concluded that neopterin may be used as a nonspecific biomarker that reflects immunological activity in pterygium and has clinical potential for evaluation of pterygium pathogenesis. These immune- or inflammatory-mediated changes were also supported by an increased KYN/TRP ratio in pterygium patients.
References
1. Diab M, ed. Lexicon of orthopaedic etymology. Amsterdam: Harwood Academic Publishers; 1999.Search in Google Scholar
2. Marcovich AL, Bahar I, Srinivasan S, Slomovic AR. Surgical management of pterygium. Int Ophthalmol Clin. 2010;50(30):47-61.10.1097/IIO.0b013e3181e218f7Search in Google Scholar
3. Di Girolamo N, Kumar RK, Coroneo MT, Wakefield D. UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2002;43(11):3430-7.Search in Google Scholar
4. Kim KW, Park SH, Wee SW, Kim JC. Overexpression of angiogenin in pterygium body fibroblasts and its association with proliferative potency. Invest Ophthalmol Vis Sci. 2013;54(9):6355-62.10.1167/iovs.13-12141Search in Google Scholar
5. Weinstein O, Rosenthal G, Zirkin H, Monos T, Lifshitz T, Argov S. Overexpression of p53 tumor suppressor gene in pterygia. Eye (Lond). 2002;16(5):619-21.10.1038/sj.eye.6700150Search in Google Scholar
6. Lucas RM, McMichael AJ, Armstrong BK, Smith WT. Estimating the global disease burden due to ultraviolet radiation exposure. Int J Epidemiol. 2008;37(3):654-67.10.1093/ije/dyn017Search in Google Scholar PubMed
7. Tsai YY, Chang KC, Lin CL, Lee H, Tsai FJ, Cheng YW, et al. p53 Expression in pterygium by immunohistochemical analysis: a series report of 127 cases and review of the literature. Cornea. 2005;24(5):583-6.10.1097/01.ico.0000154404.86462.35Search in Google Scholar
8. Golu T, Mogoanta L, Streba CT, Pirici DN, Malaescu D, Mateescu GO, et al. Pterygium: histological and immunohistochemical aspects. Rom J Morphol Embryol. 2011;52(1):153-8.Search in Google Scholar
9. Berdowska A, Zwirska-Korczala K. Neopterin measurement in clinical diagnosis. J Clin Pharm Ther. 2001;26(5):319-29.10.1046/j.1365-2710.2001.00358.xSearch in Google Scholar PubMed
10. Hoffmann G, Wirleitner B, Fuchs D. Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res. 2003;52(8):313-21.10.1007/s00011-003-1181-9Search in Google Scholar PubMed
11. Lovelace MD, Varney B, Sundaram G, Lennon MJ, Lim CK, Jacobs K, et al. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases. Neuropharmacology. 2017;112(Pt B):373-88.10.1016/j.neuropharm.2016.03.024Search in Google Scholar
12. Schrocksnadel K, Wirleitner B, Winkler C, Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta. 2006;364(1-2):82-90.10.1016/j.cca.2005.06.013Search in Google Scholar
13. Widner B, Wirleitner B, Baier-Bitterlich G, Weiss G, Fuchs D. Cellular immune activation, neopterin production, tryptophan degradation and the development of immunodeficiency. Arch Immunol Ther Exp (Warsz). 2000;48(4):251-8.Search in Google Scholar
14. Widner B, Laich A, Sperner-Unterweger B, Ledochowski M, Fuchs D. Neopterin production, tryptophan degradation, and mental depression--what is the link? Brain Behav Immun. 2002;16(5):590-5.10.1016/S0889-1591(02)00006-5Search in Google Scholar
15. Sucher R, Schroecksnadel K, Weiss G, Margreiter R, Fuchs D, Brandacher G. Neopterin, a prognostic marker in human malignancies. Cancer Lett. 2010;287(1):13-22.10.1016/j.canlet.2009.05.008Search in Google Scholar
16. Oxenkrug GF. Interferon-gamma-inducible kynurenines/ pteridines inflammation cascade: implications for ageing and ageing-associated psychiatric and medical disorders. J Neural Transm (Vienna). 2011;118(1):75-85.10.1007/s00702-010-0475-7Search in Google Scholar
17. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem. 1997;43(12):2424-6.10.1093/clinchem/43.12.2424Search in Google Scholar
18. Palabiyik SS, Keles S, Girgin G, Arpali-Tanas E, Topdagi E, Baydar T. Neopterin release and tryptophan degradation in patients with uveitis. Curr Eye Res. 2016;41(11):1513-17.10.3109/02713683.2015.1133830Search in Google Scholar
19. Widner B, Sepp N, Kowald E, Ortner U, Wirleitner B, Fritsch P, et al. Enhanced tryptophan degradation in systemic lupus erythematosus. Immunobiology. 2000;201(5):621-30.10.1016/S0171-2985(00)80079-0Search in Google Scholar
20. Girgin G, Tolga Sahin T, Fuchs D, Kasuya H, Yuksel O, Tekin E, et al. Immune system modulation in patients with malignant and benign breast disorders: tryptophan degradation and serum neopterin. Int J Biol Markers. 2009;24(4):265-70.10.1177/172460080902400408Search in Google Scholar
21. Palmer HE, Giovannoni G, Stanford MR, Wallace, GR, Graham EM. Urinary neopterin in idiopathic retinal vasculitis. Br J Ophthalmol. 2001;85(1):30-3.10.1136/bjo.85.1.30Search in Google Scholar PubMed PubMed Central
22. Laganovska G, Martinsons A, Pitrans B, Widner B, Fuchs D. Neopterin and kynurenine concentrations in aqueous humour of the anterior chamber of the eye and in serum of cataract patients with pseudoexfoliation. Pteridines. 2000;11(3):94-9.10.1515/pteridines.2000.11.3.94Search in Google Scholar
23. Cinici E, Palabiyik SS, Sipahi H, Baydar T. Nitrite, neopterin levels and tryptophan degradation in allergic conjunctivitis. Int Ophthalmol. 2018;38(5):1871-810.1007/s10792-017-0669-1Search in Google Scholar PubMed
24. Baydar T, Kemer OE, Kilicarslan B, Cardak A, Girgin G. Detection of neopterin in tear samples. Pteridines. 2016;27(1-2):13-6.10.1515/pterid-2015-0020Search in Google Scholar
© 2019 Bilge Kilicarslan et al., published by De Gruyter Open
This work is licensed under the Creative Commons Attribution 4.0 Public License.
